-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

904.O1.6 904. Outcomes Research – Non-Malignant Conditions: Blending the Old With the New: Traditional and Innovative Approaches to Determining Outcomes in Patients With Sickle Cell Disease

Symposia: Outcomes Research—Non-Malignant Conditions Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Clinical Research, health outcomes research, patient-reported outcomes, Therapies, real-world evidence
Monday, December 11, 2023: 4:30 PM-6:00 PM
Marriott Grand Ballroom 8-9 (Marriott Marquis San Diego Marina)
Oyebimpe Adesina, MD, MS, University of California and Alex A Boucher, MD, University of Minnesota Medical School
Boucher: Takeda: Research Funding; CSL Behring: Research Funding.
This session looks at various approaches including some novel ideas to determine health outcomes in patients with sickle cll disease.
4:30 PM

Oliver Shastri, MBBS1*, Orlando Agrippa2*, Laura Galimam3*, Seraj Sharif4* and Marzieh Araghi5*

1Pfizer Ltd, Surrey, ENG, GBR
2Sanius Health, London, GBR
3Lumanity, London, United Kingdom
4Pfizer, London, United Kingdom
5Pfizer Ltd, Surrey, United Kingdom

4:45 PM

Rajagopalan Subramaniam1*, Michael Kane, PhD2* and Lakshmanan Krishnamurti, MD3

1Indian Institute of Technology (IIT), Chennai, India
2Biostatistics Department, Yale School o Public Health, New Haven,, CT
3Section of Pediatric Hematology, Oncology and Bone Marrow Transplant, Yale School of Medicine, Atlanta, GA

5:00 PM

Kim Summers, PhD, MSc, BSc1*, Orlando Agrippa2*, Sanne Lugthart, MD3*, Kofi Anie4* and Paul Telfer, MD5*

1Sanius Health, London, ENG, United Kingdom
2Sanius Health, London, GBR
3University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, GBR
4Central Middlesex Hospital, London, GBR
5Blizard Institute, Queen Mary University of London, London, GBR

5:15 PM

Joseph Walden1*, Joseph R Stanek, MS2*, Leena Nahata1* and Susan Elizabeth Creary, MD, MSc1

1Nationwide Children's Hospital Research Institute, Columbus, OH
2Division of Biostatistics, Nationwide Children's Hospital, Columbus, OH

5:30 PM

Ashley Catanzarite1*, Jillian Bouck2*, Megan Matthes, PA-C, MPAS, MPH3*, Derrick L Goubeaux, DO1,4, Julia E LaMotte, PhD1,4* and Seethal A Jacob, MD, MS5,6

1Indiana University School of Medicine, Indianapolis, IN
2Center for Pediatric and Adolescent Comparative Effectiveness Research, Indiana Unvieresity School of Medicine, Indianapolis, IN
3Riley Hospital for Children at IU Health, Indianapolis, IN
4Riley Hospital for Children, Indianapolis, IN
5Children’s Health Services Research, Indiana University School of Medicine, Indianapolis, IN
6Department of Pediatrics, Division of Hematology Oncology, Riley Hospital For Children, Indianapolis, IN

5:45 PM

Charity I Oyedeji, MD1,2, Richard Faldowski, PhD3*, Bryce Reeve, PhD4*, Miriam C Morey, PhD3*, Rania Mohamed, BS5*, Reena Ravi, BS5*, Stephanie L Padrick, BSN, RN6*, Teagan Callaway, BS5* and John J Strouse, MD, PhD1

1Department of Medicine, Division of Hematology, Duke University School of Medicine, Durham, NC
2Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC
3Duke University, Durham, NC
4Department of Population Health Sciences, Duke Universty, Durham
5Duke University Medical Center, Durham, NC
6Department of Medicine, Division of Hematology, Duke University Medical Center, Durham, NC

*signifies non-member of ASH